The Causes & Treatments for Autism | Dr. Karen Parker

Andrew Huberman and Dr. Karen Parker discuss the causes, diagnosis, and emerging treatments for autism. They examine why autism rates have risen to roughly 1 in 36 US children, the genetic and environmental contributors, and the difficulty of diagnosing a heterogeneous behavioral condition. Parker walks through her research on the neuropeptides oxytocin and vasopressin, including a primate model of natural social impairment she validated in rhesus macaques. The centerpiece is her discovery that low cerebrospinal-fluid vasopressin tracks social deficits in monkeys, in children with autism, and even in infants who are later diagnosed, and that intranasal vasopressin improved social abilities in a small pilot trial. They also cover oxytocin trials, the gut microbiome-vagus nerve connection, a failed pharmaceutical trial that used the opposite (antagonist) approach, and the debunked vaccine-autism claim.

• Autism prevalence has risen to 1 in 36 US children, up from 1 in 44 just two years earlier and far above the older 1-in-150 figure.
  00:07:16
• Only two FDA-approved drugs exist for autism, both antipsychotics that treat associated irritability rather than core features.
  00:52:21
• Parker's ~200-child study showed blood oxytocin is NOT a marker of autism, but lower levels tracked greater social difficulty in everyone, including controls.
  01:30:30
• In monkeys, cerebrospinal-fluid vasopressin (not blood, not oxytocin) classified high vs low social animals nearly perfectly.
  01:49:41
• In a first human study, CSF vasopressin alone correctly classified 13 of 14 children as autistic or not.
  01:55:52
• Banked infant CSF showed babies who later developed autism already had low vasopressin levels before symptoms appeared, suggesting causality.
  02:02:35
• Intranasal vasopressin improved social abilities in autistic children across parent reports, clinician evaluations, and lab tests in a pilot trial.
  02:14:37
• A Roche trial used a vasopressin v1a receptor ANTAGONIST (the opposite of Parker's approach) and failed, indirectly supporting her agonist hypothesis.
  02:37:43

• Autism is male-biased, affecting roughly three to four boys for every one girl.
  00:08:18
• People in intense STEM fields like engineering, physics, and math carry a greater burden of autistic traits even without a diagnosis.
  00:12:27
• Oxytocin and vasopressin are ancient nine-amino-acid peptides differing by only two amino acids, hundreds of millions of years old.
  00:32:33
• Oxytocin is Greek for 'quick birth'; vasopressin has two names (arginine vasopressin and anti-diuretic hormone), causing cross-field confusion.
  00:35:08
• In sheep and goats, passage of the baby through the vaginal canal triggers oxytocin release that turns on maternal bonding.
  00:39:47
• A single injection of vasopressin into a winter male meadow vole's brain instantly switched on full paternal behavior like a light switch.
  01:23:43
• Thalidomide's limb defects were missed because safety testing was done only in mice; old-world monkeys would have revealed them.
  01:44:00
• Low CSF vasopressin tracked social symptom severity specifically, not the restricted/repetitive behaviors of autism.
  01:57:55
• A probiotic given to mice raised hypothalamic oxytocin and vasopressin via the vagus nerve; cutting the vagus abolished the rescue.
  02:30:24
• The vaccine-autism scare traced to Andrew Wakefield, who fabricated data, lost his medical license, and had his paper retracted.
  02:44:06

Books, products and media the guest or host genuinely endorsed here — with the buy link.

Affiliate link — we may earn a commission at no extra cost to you.